QURE

19.3504.35%
HK

Hugo Katus

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Prof. Hugo Katus is Co-Founder and Chief Medical Officer of AaviGen GmbH. Prof. Katus is a distinguished figure in cardiology renowned for inventing the Troponin T test, the gold standard in acute myocardial infarction (MI) diagnostics. With a medical degree from the University of Heidelberg, Germany and postdoctoral studies at Harvard Medical School, he possesses a wealth of knowledge in cardiovascular medicine. As Director of Cardiology at the University of Heidelberg, Prof. Katus spearheaded groundbreaking research and mentored a new generation of cardiologists. His research spans molecular mechanisms of heart failure, genetic determinants of cardiovascular diseases and advanced diagnostic tools. With a compassionate approach to patient care, Prof. Katus has significantly impacted the field. His leadership and expertise continue to shape the future of cardiovascular medicine, making him a luminary in the field. Prof. Katus has been the Chairman of Scientific Advisory Board at uniQure N.V. since August 2014.

Positions